First-in-Human Study of EOS100850 (Inupadenant) in Patients with Cancer
Clinical trial NCT03873883 · COMPLETED
Trial details
- NCT number
- NCT03873883
- Sponsor
- iTeos Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-05
- Primary completion
- 2024-05-28
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.